These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1491043)

  • 1. Determination of thalidomide in plasma and blood by high-performance liquid chromatography: avoiding hydrolytic degradation.
    Eriksson T; Björkman S; Fyge A; Ekberg H
    J Chromatogr; 1992 Nov; 582(1-2):211-6. PubMed ID: 1491043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the thalidomide analogues 2-(2,6-dioxopiperidine-3-yl)phthalimidine (EM 12), 2-(2,6-dioxopiperidine-4-yl)phthalimidine (EM 16) and their metabolites in biological samples.
    Winckler K; Klinkmüller KD; Schmahl HJ
    J Chromatogr; 1989 Mar; 488(2):417-25. PubMed ID: 2501333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative determination of thalidomide in human serum with high-performance liquid chromatography using protein precipitation with trichloroacetic acid and ultraviolet detection.
    Toraño JS; Verbon A; Guchelaar HJ
    J Chromatogr B Biomed Sci Appl; 1999 Nov; 734(2):203-10. PubMed ID: 10595718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of thalidomide by high performance liquid chromatography: plasma pharmacokinetic studies in the rat.
    Yang X; Hu Z; Chan SY; Ho PC; Chan E; Duan W; Goh BC; Zhou S
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):299-304. PubMed ID: 16085147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent determination of thalidomide in rat blood, brain and bile using multiple microdialysis coupled to liquid chromatography.
    Huang YJ; Liao JF; Tsai TH
    Biomed Chromatogr; 2005 Sep; 19(7):488-93. PubMed ID: 15651096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide enantiomers: determination in biological samples by HPLC and vancomycin-CSP.
    Murphy-Poulton SF; Boyle F; Gu XQ; Mather LE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):48-56. PubMed ID: 16321578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of thalidomide by high performance liquid chromatography: methodological strategy for clinical trials.
    Lyon AW; Duran G; Raisys VA
    Clin Biochem; 1995 Aug; 28(4):467-70. PubMed ID: 8521603
    [No Abstract]   [Full Text] [Related]  

  • 8. A Wide Linearity Range Method for the Determination of Lenalidomide in Plasma by High-Performance Liquid Chromatography: Application to Pharmacokinetic Studies.
    Guglieri-López B; Pérez-Pitarch A; Martinez-Gómez MA; Porta-Oltra B; Climente-Martí M; Merino-Sanjuán M
    J Lab Autom; 2016 Dec; 21(6):806-810. PubMed ID: 26956578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of thalidomide in transport buffer for Caco-2 cell monolayers by high-performance liquid chromatography with ultraviolet detection.
    Zhou S; Li Y; Kestell P; Paxton JW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Feb; 785(1):165-73. PubMed ID: 12535849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantiomers of thalidomide: blood distribution and the influence of serum albumin on chiral inversion and hydrolysis.
    Eriksson T; Björkman S; Roth B; Fyge A; Höglund P
    Chirality; 1998; 10(3):223-8. PubMed ID: 9499573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in analytical determination of thalidomide and its metabolites.
    Bosch ME; Sánchez AJ; Rojas FS; Ojeda CB
    J Pharm Biomed Anal; 2008 Jan; 46(1):9-17. PubMed ID: 18023317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatographic assay of plasma thalidomide: stabilization of specimens and determination of a tentative therapeutic range for chronic graft-versus-host disease.
    Boughton BJ; Sheehan TM; Wood J; O'Brien D; Butler M; Simpson A; Hale KA
    Ann Clin Biochem; 1995 Jan; 32 ( Pt 1)():79-83. PubMed ID: 7762955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High performance liquid chromatographic determination of thalidomide in patients affected by hepatocellular carcinoma.
    Saccomanni G; Turini V; Manera C; Placanica G; Salè EO; Jemos C; Giorgi M; Macchia M
    J Pharm Biomed Anal; 2008 Sep; 48(2):447-51. PubMed ID: 18282676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of thalidomide and its major metabolites by high-performance liquid chromatography.
    Czejka MJ; Koch HP
    J Chromatogr; 1987 Jan; 413():181-7. PubMed ID: 3558667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of CC-5013, an analogue of thalidomide, in human plasma by liquid chromatography-mass spectrometry.
    Tohnya TM; Hwang K; Lepper ER; Fine HA; Dahut WL; Venitz J; Sparreboom A; Figg WD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Nov; 811(2):135-41. PubMed ID: 15522712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the stationary phase on the stability of thalidomide and comparison of different methods for the quantification of thalidomide in tablets using high-temperature liquid chromatography.
    Giegold S; Holzhauser M; Kiffmeyer T; Tuerk J; Teutenberg T; Rosenhagen M; Hennies D; Hoppe-Tichy T; Wenclawiak B
    J Pharm Biomed Anal; 2008 Mar; 46(4):625-30. PubMed ID: 18248931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new method for determination of both thalidomide enantiomers using HPLC systems.
    Sembongi K; Tanaka M; Sakurada K; Kobayashi M; Itagaki S; Hirano T; Iseki K
    Biol Pharm Bull; 2008 Mar; 31(3):497-500. PubMed ID: 18310917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxylated metabolites of thalidomide: formation in-vitro and in-vivo in man.
    Eriksson T; Björkman S; Roth B; Björk H; Höglund P
    J Pharm Pharmacol; 1998 Dec; 50(12):1409-16. PubMed ID: 10052858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of thalidomide in rabbits and rats.
    Schumacher H; Blake DA; Gillette JR
    J Pharmacol Exp Ther; 1968 Mar; 160(1):201-11. PubMed ID: 5639105
    [No Abstract]   [Full Text] [Related]  

  • 20. The determination of a potential impurity in Thalidomide drug substance and product by HPLC with indirect UV detection.
    Li J; Jaworsky MS; Stirling DI
    J Pharm Biomed Anal; 2003 Feb; 31(1):19-27. PubMed ID: 12560045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.